BlackRock Health Sciences Trust (NYSE:BME – Get Free Report) declared a monthly dividend on Friday, February 27th. Stockholders of record on Friday, May 15th will be given a dividend of 0.2621 per share on Friday, May 29th. This represents a c) dividend on an annualized basis and a dividend yield of 8.0%. The ex-dividend date is Friday, May 15th.
BlackRock Health Sciences Trust Trading Up 1.5%
BME opened at $39.35 on Wednesday. BlackRock Health Sciences Trust has a one year low of $34.93 and a one year high of $42.74. The business’s 50-day simple moving average is $39.57 and its 200-day simple moving average is $40.46.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the company. Sound Income Strategies LLC purchased a new position in BlackRock Health Sciences Trust during the 1st quarter worth approximately $36,000. Northwestern Mutual Wealth Management Co. grew its stake in BlackRock Health Sciences Trust by 22.2% during the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock worth $53,000 after buying an additional 257 shares during the last quarter. Fifth Third Bancorp purchased a new position in BlackRock Health Sciences Trust during the 1st quarter worth approximately $180,000. Geneos Wealth Management Inc. grew its stake in BlackRock Health Sciences Trust by 200.0% during the 2nd quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock worth $179,000 after buying an additional 3,266 shares during the last quarter. Finally, Money Concepts Capital Corp purchased a new position in BlackRock Health Sciences Trust during the 1st quarter worth approximately $209,000.
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.
See Also
- Five stocks we like better than BlackRock Health Sciences Trust
- A Real Biggie Deal: Wendy’s Serves Up a Juicy Buyout Arbitrage
- Ally Financial Is Back to Basics—And Investors Are Watching
- Navitas Breaks Out on India Deal, Validating High-Power AI Pivot
- Navy Catalyst Ignites Odysight’s Growth Engine
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.
